Annual EBIT
-$6.05 M
+$942.90 K+13.49%
December 1, 2023
Summary
- As of February 7, 2025, XRTX annual earnings before interest & taxes is -$6.05 million, with the most recent change of +$942.90 thousand (+13.49%) on December 1, 2023.
- During the last 3 years, XRTX annual EBIT has fallen by -$5.05 million (-506.54%).
- XRTX annual EBIT is now -20394.92% below its all-time high of -$29.50 thousand, reached on February 1, 2015.
Performance
XRTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$874.70 K
+$619.00 K+41.44%
September 1, 2024
Summary
- As of February 7, 2025, XRTX quarterly earnings before interest & taxes is -$874.70 thousand, with the most recent change of +$619.00 thousand (+41.44%) on September 1, 2024.
- Over the past year, XRTX quarterly EBIT has increased by +$109.00 thousand (+11.08%).
- XRTX quarterly EBIT is now -2233.41% below its all-time high of $41.00 thousand, reached on December 1, 2018.
Performance
XRTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$4.44 M
+$518.60 K+10.46%
September 1, 2024
Summary
- As of February 7, 2025, XRTX TTM earnings before interest & taxes is -$4.44 million, with the most recent change of +$518.60 thousand (+10.46%) on September 1, 2024.
- Over the past year, XRTX TTM EBIT has increased by +$1.61 million (+26.55%).
- XRTX TTM EBIT is now -75166.10% below its all-time high of -$5900.00, reached on May 1, 2014.
Performance
XRTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
XRTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.5% | +11.1% | +26.6% |
| 3 y3 years | -506.5% | +54.1% | +52.4% |
| 5 y5 years | -119.4% | +54.1% | +52.4% |
XRTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -368.1% | +13.5% | at high | +69.6% | -51.2% | +56.9% |
| 5 y | 5-year | -1233.2% | +13.5% | -4985.5% | +69.6% | -1126.4% | +56.9% |
| alltime | all time | <-9999.0% | +13.5% | -2233.4% | +69.6% | <-9999.0% | +56.9% |
XORTX Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$874.70 K(-41.4%) | -$4.44 M(-10.5%) |
| Jun 2024 | - | -$1.49 M(+37.2%) | -$4.96 M(-5.1%) |
| Mar 2024 | - | -$1.09 M(+10.7%) | -$5.23 M(-13.5%) |
| Dec 2023 | -$6.05 M(-13.5%) | -$983.70 K(-29.4%) | -$6.05 M(-21.7%) |
| Sep 2023 | - | -$1.39 M(-20.9%) | -$7.72 M(-8.4%) |
| Jun 2023 | - | -$1.76 M(-7.6%) | -$8.43 M(-9.5%) |
| Mar 2023 | - | -$1.91 M(-28.3%) | -$9.32 M(-9.4%) |
| Dec 2022 | -$6.99 M(+441.1%) | -$2.66 M(+26.5%) | -$10.29 M(+15.1%) |
| Sep 2022 | - | -$2.10 M(-20.7%) | -$8.94 M(+25.0%) |
| Jun 2022 | - | -$2.65 M(-7.8%) | -$7.16 M(+37.6%) |
| Mar 2022 | - | -$2.88 M(+119.4%) | -$5.20 M(+77.2%) |
| Dec 2021 | -$1.29 M(+29.6%) | - | - |
| Dec 2021 | - | -$1.31 M(+312.9%) | -$2.94 M(+46.1%) |
| Sep 2021 | - | -$317.40 K(-54.5%) | -$2.01 M(+0.0%) |
| Jun 2021 | - | -$698.00 K(+14.4%) | -$2.01 M(+26.9%) |
| Mar 2021 | - | -$610.40 K(+58.6%) | -$1.58 M(+59.9%) |
| Dec 2020 | -$996.80 K(+119.8%) | -$384.80 K(+21.5%) | -$990.30 K(+33.2%) |
| Sep 2020 | - | -$316.80 K(+16.7%) | -$743.70 K(+42.3%) |
| Jun 2020 | - | -$271.50 K(+1478.5%) | -$522.50 K(+44.3%) |
| Mar 2020 | - | -$17.20 K(-87.6%) | -$362.10 K(-0.3%) |
| Dec 2019 | -$453.50 K | -$138.20 K(+44.6%) | -$363.10 K(+97.4%) |
| Sep 2019 | - | -$95.60 K(-14.0%) | -$183.90 K(-43.0%) |
| Jun 2019 | - | -$111.10 K(+510.4%) | -$322.90 K(-22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$18.20 K(-144.4%) | -$414.60 K(-84.9%) |
| Dec 2018 | -$2.76 M(+664.5%) | $41.00 K(-117.5%) | -$2.75 M(-8.7%) |
| Sep 2018 | - | -$234.60 K(+15.7%) | -$3.02 M(+3.9%) |
| Jun 2018 | - | -$202.80 K(-91.4%) | -$2.90 M(+6.1%) |
| Mar 2018 | - | -$2.36 M(+1141.8%) | -$2.73 M(+498.4%) |
| Dec 2017 | -$360.50 K(+145.7%) | -$189.80 K(+514.2%) | -$456.80 K(+71.1%) |
| Nov 2017 | - | -$30.90 K(-54.0%) | -$267.00 K(-4.3%) |
| Sep 2017 | - | -$67.20 K(+25.1%) | -$278.90 K(+31.7%) |
| Aug 2017 | - | -$53.70 K(+52.6%) | -$211.70 K(+7.0%) |
| May 2017 | - | -$35.20 K(-26.2%) | -$197.80 K(+0.7%) |
| Mar 2017 | - | -$47.70 K(+47.7%) | -$196.50 K(+32.1%) |
| Feb 2017 | -$146.70 K(-51.5%) | -$32.30 K(-24.5%) | -$148.80 K(+42.7%) |
| Dec 2016 | -$302.20 K(+100.1%) | - | - |
| Nov 2016 | - | -$42.80 K(+7.5%) | -$104.30 K(-27.1%) |
| Aug 2016 | - | -$39.80 K(+17.4%) | -$143.10 K(+3.3%) |
| May 2016 | - | -$33.90 K(-377.9%) | -$138.50 K(-10.6%) |
| Feb 2016 | -$151.00 K(+411.9%) | $12.20 K(-115.0%) | -$155.00 K(-13.7%) |
| Nov 2015 | - | -$81.60 K(+131.8%) | -$179.70 K(+73.3%) |
| Aug 2015 | - | -$35.20 K(-30.2%) | -$103.70 K(+39.0%) |
| May 2015 | - | -$50.40 K(+303.2%) | -$74.60 K(+147.8%) |
| Feb 2015 | -$29.50 K | -$12.50 K(+123.2%) | -$30.10 K(+71.0%) |
| Nov 2014 | - | -$5600.00(-8.2%) | -$17.60 K(+46.7%) |
| Aug 2014 | - | -$6100.00(+3.4%) | -$12.00 K(+103.4%) |
| May 2014 | - | -$5900.00 | -$5900.00 |
FAQ
- What is XORTX Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for XORTX Therapeutics?
- What is XORTX Therapeutics annual EBIT year-on-year change?
- What is XORTX Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for XORTX Therapeutics?
- What is XORTX Therapeutics quarterly EBIT year-on-year change?
- What is XORTX Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for XORTX Therapeutics?
- What is XORTX Therapeutics TTM EBIT year-on-year change?
What is XORTX Therapeutics annual earnings before interest & taxes?
The current annual EBIT of XRTX is -$6.05 M
What is the all time high annual EBIT for XORTX Therapeutics?
XORTX Therapeutics all-time high annual earnings before interest & taxes is -$29.50 K
What is XORTX Therapeutics annual EBIT year-on-year change?
Over the past year, XRTX annual earnings before interest & taxes has changed by +$942.90 K (+13.49%)
What is XORTX Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of XRTX is -$874.70 K
What is the all time high quarterly EBIT for XORTX Therapeutics?
XORTX Therapeutics all-time high quarterly earnings before interest & taxes is $41.00 K
What is XORTX Therapeutics quarterly EBIT year-on-year change?
Over the past year, XRTX quarterly earnings before interest & taxes has changed by +$109.00 K (+11.08%)
What is XORTX Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of XRTX is -$4.44 M
What is the all time high TTM EBIT for XORTX Therapeutics?
XORTX Therapeutics all-time high TTM earnings before interest & taxes is -$5900.00
What is XORTX Therapeutics TTM EBIT year-on-year change?
Over the past year, XRTX TTM earnings before interest & taxes has changed by +$1.61 M (+26.55%)